Successful neoadjuvant chemotherapy plus sintilimab for locally advanced cervical cancer: case series and review of the literature

BACKGROUND: The locally advanced cervical cancer (LACC) of FIGO stage IB3-IIA2 is characterized by large local mass, poor prognosis and survival rate. Tumor response to neoadjuvant chemotherapy for LACC, utilized as a surrogate endpoint, is urgently needed to improve. Given that the antitumor immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Linlin, Deng, Xianbo, Guo, Shuang, Yang, Shouhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521576/
https://www.ncbi.nlm.nih.gov/pubmed/37752528
http://dx.doi.org/10.1186/s13000-023-01394-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521576/
https://www.ncbi.nlm.nih.gov/pubmed/37752528
http://dx.doi.org/10.1186/s13000-023-01394-w

Ejemplares similares